Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Spinal Muscular Atrophy | Case report

Clinical characterizations of three adults with genetically confirmed spinal muscular atrophy: a case series

Authors: Cempaka Thursina Srie Setyaningrum, Indra Sari Kusuma Harahap, Dian Kesumapramudya Nurputra, Mawaddah Ar Rochmah, Ahmad Hamim Sadewa, Giga Hasabi Alkarani, Nur Imma Fatimah Harahap

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Spinal muscular atrophy is a recessively inherited autosomal neuromuscular disorder, with characteristic progressive muscle weakness. Most spinal muscular atrophy cases clinically manifest during infancy or childhood, although it may first manifest in adulthood. Although spinal muscular atrophy has come to the era of newborn screening and promising treatments, genetically confirmed spinal muscular atrophy patients are still rare in third world countries, including Indonesia.

Case presentations

We presented three Indonesian patients with spinal muscular atrophy genetically confirmed during adulthood. The first case was a 40-year-old male who presented with weakness in his lower limbs that started when he was 9 years old. At the age of 16 years, he could no longer walk and started using a wheelchair. He first came to our clinic at the age of 38 years, and was diagnosed with spinal muscular atrophy 2 years later. The second patient was a 58-year-old male who presented with lower limb weakness since he was 12 years old. Owing to the geographical distance and financial problems, he was referred to our clinic at the age of 56 years, when he already used a walker to walk. Lastly, the third patient was a 28-year-old woman, who was in the first semester of her second pregnancy, and who presented with slowly progressing lower limb weakness. Her limb weakness began at the age of 8 years, and slowly progressed until she became dependent on her wheelchair 8 years later until now. She had successfully given birth to a healthy daughter 3 years before her first visit to our clinic. All three patients were diagnosed with neuromuscular disorder diseases, with the differential diagnoses of Duchenne muscular dystrophy, spinal muscular atrophy, and Becker muscular dystrophy. These patients were finally confirmed to have spinal muscular atrophy due to SMN1 deletion by polymerase chain reaction and restriction fragment length polymorphism.

Conclusions

Many genetic diseases are often neglected in developing countries owing to the difficulty in diagnosis and unavailable treatment. Our case series focused on the disease courses, diagnosis difficulties, and clinical presentations of three patients that finally lead to diagnoses of spinal muscular atrophy.
Literature
2.
go back to reference Badv RS, Nilipour Y, Dehgolan SR, et al. A novel case report of spinal muscular atrophy with progressive myoclonic epilepsy from Iran. Int Med Case Rep J. 2019;12:155–9.CrossRef Badv RS, Nilipour Y, Dehgolan SR, et al. A novel case report of spinal muscular atrophy with progressive myoclonic epilepsy from Iran. Int Med Case Rep J. 2019;12:155–9.CrossRef
3.
go back to reference Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy. Part I: Recommendations for diagnosis, rehabilitation, orthopedic, and nutritional care. Neuromuscul Disord. 2018;28:103–15.CrossRefPubMed Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy. Part I: Recommendations for diagnosis, rehabilitation, orthopedic, and nutritional care. Neuromuscul Disord. 2018;28:103–15.CrossRefPubMed
4.
go back to reference Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51:157–67.CrossRefPubMed Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51:157–67.CrossRefPubMed
5.
go back to reference Verhaart IEC, Robertson A, Leary R, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264:1465–73.CrossRefPubMedPubMedCentral Verhaart IEC, Robertson A, Leary R, et al. A multi-source approach to determine SMA incidence and research ready population. J Neurol. 2017;264:1465–73.CrossRefPubMedPubMedCentral
6.
go back to reference Lefebvre S, Bürglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155–65.CrossRefPubMed Lefebvre S, Bürglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155–65.CrossRefPubMed
7.
go back to reference Velasco E, Valero C, Valero A, et al. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet. 1996;5(2):257–63.CrossRefPubMed Velasco E, Valero C, Valero A, et al. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet. 1996;5(2):257–63.CrossRefPubMed
8.
go back to reference McAndrew PE, Parsons DW, Simard LR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet. 1997;60(6):1411–22.CrossRefPubMedPubMedCentral McAndrew PE, Parsons DW, Simard LR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet. 1997;60(6):1411–22.CrossRefPubMedPubMedCentral
9.
go back to reference Ar Rochmah M, Harahap NIF, Niba ETE, et al. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried-blood spot DNA. Brain Dev. 2017;39:774–82.CrossRefPubMed Ar Rochmah M, Harahap NIF, Niba ETE, et al. Genetic screening of spinal muscular atrophy using a real-time modified COP-PCR technique with dried-blood spot DNA. Brain Dev. 2017;39:774–82.CrossRefPubMed
11.
go back to reference Farooq FT, Holcik M, MacKenzie A. Spinal muscular atrophy: classification, diagnosis, background, molecular mechanism and development of therapeutics. Neurodegener Dis. 2013;1:561–79. Farooq FT, Holcik M, MacKenzie A. Spinal muscular atrophy: classification, diagnosis, background, molecular mechanism and development of therapeutics. Neurodegener Dis. 2013;1:561–79.
12.
go back to reference Campana ES, Roy SQ. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander Disease). Arch Pediatr. 2020;27:7523–8. Campana ES, Roy SQ. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander Disease). Arch Pediatr. 2020;27:7523–8.
13.
go back to reference Wilson K, Faelan C, Kane JCP, Rudmann DG, Moore SA, Frank D, et al. Duchenne and Becker muscular dystrophies; a review of animal models, clinical end points, and biomarker quantification. Toxicol Pathol. 2017;45(7):962.CrossRef Wilson K, Faelan C, Kane JCP, Rudmann DG, Moore SA, Frank D, et al. Duchenne and Becker muscular dystrophies; a review of animal models, clinical end points, and biomarker quantification. Toxicol Pathol. 2017;45(7):962.CrossRef
14.
go back to reference Hardiman O, Al-Chalabi A, Chiò A, Logroscino G, Robberrecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.CrossRefPubMed Hardiman O, Al-Chalabi A, Chiò A, Logroscino G, Robberrecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.CrossRefPubMed
15.
go back to reference Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):252.CrossRef Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):252.CrossRef
17.
go back to reference Gambardella A, Mazzei R, Toscano A, Annesi G, Pasqua A, Annesi F, et al. Spinal muscular atrophy due to an isolated deletion of exon 8 of the telometric survival motor neuron gene. Ann Neurol. 1998;44(5):836–9.CrossRefPubMed Gambardella A, Mazzei R, Toscano A, Annesi G, Pasqua A, Annesi F, et al. Spinal muscular atrophy due to an isolated deletion of exon 8 of the telometric survival motor neuron gene. Ann Neurol. 1998;44(5):836–9.CrossRefPubMed
18.
go back to reference Velasco E, Valero C, Valero A, et al. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies and ‘BCD541 and SMA phenotype. Hum Mol Gennet. 1996;5:258. Velasco E, Valero C, Valero A, et al. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies and ‘BCD541 and SMA phenotype. Hum Mol Gennet. 1996;5:258.
19.
go back to reference Parano E, Pavone L, Falsaperla R, et al. Molecularr basis of phenotypic heterogeneity in siblings with Spinal Muscular Atrophy. Ann Neurol. 1996;40:250.CrossRef Parano E, Pavone L, Falsaperla R, et al. Molecularr basis of phenotypic heterogeneity in siblings with Spinal Muscular Atrophy. Ann Neurol. 1996;40:250.CrossRef
20.
go back to reference Schorling DC, Pechmann A, Kirschner J. Advances in treatment of spinal muscular atrophy: new phenotypes, new challenges, new implications for care. J Neuromusc Dis. 2020;7:1–13.CrossRef Schorling DC, Pechmann A, Kirschner J. Advances in treatment of spinal muscular atrophy: new phenotypes, new challenges, new implications for care. J Neuromusc Dis. 2020;7:1–13.CrossRef
Metadata
Title
Clinical characterizations of three adults with genetically confirmed spinal muscular atrophy: a case series
Authors
Cempaka Thursina Srie Setyaningrum
Indra Sari Kusuma Harahap
Dian Kesumapramudya Nurputra
Mawaddah Ar Rochmah
Ahmad Hamim Sadewa
Giga Hasabi Alkarani
Nur Imma Fatimah Harahap
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03633-y

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue